Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A London

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Journal of Comparative Pathology|November 1, 1996
Expression of stem cell factor receptor (c-kit) by the malignant mast cells from spontaneous canine mast cell tumoursC A London, W C Kisseberth, S J Galli, et al.
Veterinary and Comparative Oncology|June 17, 2017
Prospective evaluation of toceranib phosphate in metastatic canine osteosarcomaT Laver, C A London, D M Vail, et al.
Journal of Veterinary Internal Medicine|December 20, 2011
Multicenter prospective trial of hypofractionated radiation treatment, toceranib, and prednisone for measurable canine mast cell tumorsK S Carlsten, C A London, S Haney, et al.
Veterinary and Comparative Oncology|January 13, 2012
Met interacts with EGFR and Ron in canine osteosarcomaJ K McCleese, M D Bear, S K Kulp, et al.
The Journal of Experimental Medicine|October 7, 1997
Role of interleukin 12 and costimulators in T cell anergy in vivoL Van Parijs, V L Perez, A Biuckians, et al.
Experimental Hematology|April 21, 1999
Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kitC A London, S J Galli, T Yuuki, et al.
Veterinary and Comparative Oncology|November 7, 2009
Prevalence of elevated alanine transaminase activity in dogs treated with CCNU (Lomustine)*K Hosoya, L K Lord, A Lara-Garcia, et al.
Journal of Veterinary Internal Medicine|March 4, 2008
A phase II clinical trial of vinorelbine in dogs with cutaneous mast cell tumorsI A Grant, C O Rodriguez, M S Kent, et al.
The Journal of Experimental Medicine|June 22, 2000
Expression of bcl-X(L) restores cell survival, but not proliferation off effector differentiation, in CD28-deficient T lymphocytesA M Dahl, C Klein, P G Andres, et al.
Journal of Immunological Methods|August 4, 2007
Arginine-rich cell-penetrating peptides facilitate delivery of antisense oligomers into murine leukocytes and alter pre-mRNA splicingN B Marshall, S K Oda, C A London, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal of Comparative Pathology|November 1, 1996
Expression of stem cell factor receptor (c-kit) by the malignant mast cells from spontaneous canine mast cell tumoursC A London, W C Kisseberth, S J Galli, et al.
Veterinary and Comparative Oncology|June 17, 2017
Prospective evaluation of toceranib phosphate in metastatic canine osteosarcomaT Laver, C A London, D M Vail, et al.
Journal of Veterinary Internal Medicine|December 20, 2011
Multicenter prospective trial of hypofractionated radiation treatment, toceranib, and prednisone for measurable canine mast cell tumorsK S Carlsten, C A London, S Haney, et al.
Veterinary and Comparative Oncology|January 13, 2012
Met interacts with EGFR and Ron in canine osteosarcomaJ K McCleese, M D Bear, S K Kulp, et al.
The Journal of Experimental Medicine|October 7, 1997
Role of interleukin 12 and costimulators in T cell anergy in vivoL Van Parijs, V L Perez, A Biuckians, et al.
Experimental Hematology|April 21, 1999
Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kitC A London, S J Galli, T Yuuki, et al.
Veterinary and Comparative Oncology|November 7, 2009
Prevalence of elevated alanine transaminase activity in dogs treated with CCNU (Lomustine)*K Hosoya, L K Lord, A Lara-Garcia, et al.
Journal of Veterinary Internal Medicine|March 4, 2008
A phase II clinical trial of vinorelbine in dogs with cutaneous mast cell tumorsI A Grant, C O Rodriguez, M S Kent, et al.
The Journal of Experimental Medicine|June 22, 2000
Expression of bcl-X(L) restores cell survival, but not proliferation off effector differentiation, in CD28-deficient T lymphocytesA M Dahl, C Klein, P G Andres, et al.
Journal of Immunological Methods|August 4, 2007
Arginine-rich cell-penetrating peptides facilitate delivery of antisense oligomers into murine leukocytes and alter pre-mRNA splicingN B Marshall, S K Oda, C A London, et al.
Pageof 3